COMPASS Pathways plc
HealthcareNASDAQ:CMPS · NASDAQ Global Select
+$0.67 today
Vol 2.50M · Avg 4.08M
Management
Put operating results in leadership context
Review returns on capital, executive background, insider transactions, and growth quality to judge whether management is compounding value well.
Return Metrics
ROE, ROIC & ROA over time
ROE
544.7%
avg 18.4%
ROIC
996.5%
avg 76.5%
ROA
-136.8%
avg -57.9%
Analysis
ROIC is currently the strongest return metric at 996.5% versus its period average of 76.5%. 2 of 3 return metrics are above their quality threshold, which helps indicate how efficiently the company turns capital and assets into profit.
Management
Key executives, compensation & ownership
| Name | Title | Compensation | Tenure | Age | Shares Owned | Ownership % |
|---|---|---|---|---|---|---|
Kabir Nath | Chief Executive Officer & Director | $1.07M | — | 62 | $367,815.00 | 0.38% |
Teri Loxam | Chief Financial Officer | $734,149.00 | — | 53 | $157,635.00 | 0.16% |
Guy Goodwin | Chief Medical Officer | $632,409.00 | — | 78 | $115,600.00 | 0.12% |
Benjamin Harber | Company Secretary | — | — | 49 | — | — |
Steve Levine | Chief Patient Officer | — | — | — | — | — |
Lars Christian Wilde | Senior Advisor | — | — | 40 | — | — |
Susan C. Stansfield | Advisor | — | — | — | — | — |
Michael Gold | Chief Research & Development Officer | — | — | 65 | $45,000.00 | 0.05% |
Stephen D. Schultz | Senior Vice President of Investor Relations | — | — | — | $21,110.00 | 0.02% |
Lori Englebert | Chief Commercial Officer | — | — | 48 | — | — |
Insider Trading
SEC Form 4 transactions — last 12 months
No insider transactions in the last 12 months.
Growth Analysis
Historical CAGR & forward analyst estimates
| Metric | 10yr | 5yr | 3yr | Fwd Est. |
|---|---|---|---|---|
| EPS | N/A | N/A | N/A | N/A2 analysts |
| Revenue | N/A | N/A | N/A | N/A4 analysts |
| Net Income | N/A | N/A | N/A | N/A4 analysts |
| EBIT | N/A | N/A | N/A | N/A4 analysts |
Analysis
Analysis will appear once historical growth or forward estimates are available for this company.
Competitors
Peer companies in the same sector
KalVista Pharmaceuticals, Inc.
NASDAQ:KALV
$1.44B
Avanos Medical, Inc.
NYSE:AVNS
$1.17B
Talkspace, Inc.
NASDAQ:TALK
$872.74M
Enhabit, Inc.
EHAB
$706.91M
Sonida Senior Living, Inc.
NYSE:SNDA
$700.96M
Varex Imaging Corporation
NASDAQ:VREX
$464.78M
4D Molecular Therapeutics, Inc.
NASDAQ:FDMT
$461.60M
Community Health Systems, Inc.
NYSE:CYH
$439.66M
Prothena Corporation plc
NASDAQ:PRTA
$431.91M
Gossamer Bio, Inc.
GOSS
$38.00M
Who manages CMPS?
COMPASS Pathways plc (CMPS) lists 10 active executives. The top listed executive is Guy Goodwin, Chief Medical Officer.
Are CMPS insiders buying or selling?
Recent insider activity shows net selling of $5.69M.
Explore More
Continue the stock analysis
Jump to another research area for this company.